FCGR3A and neoplasm: Moreover, when scrutinizing the same combinations in CD3-negative cells, the CD56/CD16 combination remains comparable between the tumor and non-tumor regions, while the CD122/CD94 combination was exclusively detected in the tumor region and not in the non-tumor area (Fig. 6B).